MedPath

Altair Therapeutics, Inc.

Altair Therapeutics, Inc. logo
🇺🇸United States
Ownership
Private
Established
2007-01-01
Employees
1
Market Cap
-
Website
http://www.altairthera.com

Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma

Phase 2
Completed
Conditions
Asthma
Interventions
Drug: Physiologic saline solution
First Posted Date
2009-07-17
Last Posted Date
2010-07-23
Lead Sponsor
Altair Therapeutics, Inc.
Target Recruit Count
30
Registration Number
NCT00941577

A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma

Phase 1
Completed
Conditions
Asthma
Interventions
Drug: Physiologic saline solution
First Posted Date
2008-04-15
Last Posted Date
2009-06-25
Lead Sponsor
Altair Therapeutics, Inc.
Target Recruit Count
80
Registration Number
NCT00658749
Locations
🇺🇸

Contract Research Organization (CRO) appointed by Altair Therapeutics--Altair's offices are in:, San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath